Related Experiment Videos
Diarrheal disease. Established pathogens, new pathogens, and progress in vaccine development
1Division of Pediatric Gastroenterology and Nutrition, Children's Hospital Medical Center, Cincinnati, Ohio.
Gastroenterology Clinics of North America
|December 1, 1994
Summary
Preventive measures for infectious diarrhea, like vaccines, have lagged despite advances in treatment. Further research into pathogen mechanisms and gut immunity is crucial for future vaccine development.
Area of Science:
- Infectious Diseases
- Vaccinology
- Immunology
Background:
- Oral rehydration has significantly reduced infectious diarrhea morbidity and mortality.
- Vaccine development for infectious diarrhea has faced challenges over the past decade.
Purpose of the Study:
- To highlight the slow progress in preventive measures for infectious diarrhea, particularly vaccine development.
- To identify key challenges hindering the creation of effective diarrhea vaccines.
Main Methods:
- This study is a review of the current state of infectious diarrhea prevention and vaccine development.
- It analyzes the factors contributing to the slow progress in the field.
Main Results:
- Despite numerous candidate vaccines, none have been approved for general use.
- Key challenges include undefined pathophysiology of pathogens and the complexity of the gastrointestinal immune system.
Conclusions:
- Significant advancements in understanding pathogen mechanisms and gut immunity are needed.
- Accelerated progress in infectious diarrhea vaccine development is anticipated with increased knowledge in these areas.